- Home
- ARWR vs CPK Comparison
ARWR vs CPK Comparison
Compare ARWR & CPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- CPK
- Stock Information
- Founded
- ARWR 2003
- CPK 1990
- Country
- ARWR United States
- CPK United States
- Employees
- ARWR N/A
- CPK N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- CPK Oil & Gas Production
- Sector
- ARWR Health Care
- CPK Utilities
- Exchange
- ARWR Nasdaq
- CPK Nasdaq
- Market Cap
- ARWR 1.8B
- CPK 2.8B
- IPO Year
- ARWR 1993
- CPK N/A
- Fundamental
- Price
- ARWR $18.31
- CPK $123.94
- Analyst Decision
- ARWR Buy
- CPK Hold
- Analyst Count
- ARWR 8
- CPK 2
- Target Price
- ARWR $43.71
- CPK $126.50
- AVG Volume (30 Days)
- ARWR 1.6M
- CPK 161.4K
- Earning Date
- ARWR 08-07-2025
- CPK 08-07-2025
- Dividend Yield
- ARWR N/A
- CPK 2.22%
- EPS Growth
- ARWR N/A
- CPK 9.39
- EPS
- ARWR N/A
- CPK 5.43
- Revenue
- ARWR $545,209,000.00
- CPK $840,200,000.00
- Revenue This Year
- ARWR $21,924.50
- CPK $13.95
- Revenue Next Year
- ARWR N/A
- CPK $3.52
- P/E Ratio
- ARWR N/A
- CPK $22.77
- Revenue Growth
- ARWR 1436.97
- CPK 20.34
- 52 Week Low
- ARWR $9.57
- CPK $108.43
- 52 Week High
- ARWR $30.41
- CPK $136.73
- Technical
- Relative Strength Index (RSI)
- ARWR 66.51
- CPK 54.44
- Support Level
- ARWR $16.45
- CPK $120.22
- Resistance Level
- ARWR $19.24
- CPK $124.33
- Average True Range (ATR)
- ARWR 0.79
- CPK 2.35
- MACD
- ARWR 0.25
- CPK 0.42
- Stochastic Oscillator
- ARWR 77.43
- CPK 78.97
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About CPK Chesapeake Utilities Corporation
Chesapeake Utilities Corp is a diversified energy delivery company that is engaged in natural gas transmission and distribution, electricity generation and distribution, propane gas distribution, mobile compressed natural gas utility services and solutions and other businesses. The company operates in two reportable segments, Regulated Energy and Unregulated Energy. The company's natural gas and electric distribution operations in Delaware, Maryland and Florida are subject to regulation by PSC. Eastern Shore, its natural gas transmission is subject to regulation by the FERC and Peninsula Pipeline and Aspire Energy Express, its intrastate pipeline subsidiaries, are subject to regulation by the Florida PSC and Public Utilities Commission of Ohio, respectively.